Loading…

Analysis of brain edema in RHAPSODY

Background: Cerebral edema is a secondary complication of acute ischemic stroke, but its time course and imaging markers are not fully understood. Recently, net water uptake (NWU) has been proposed as a novel marker of edema. Aims: Studying the RHAPSODY trial cohort, we sought to characterize the ti...

Full description

Saved in:
Bibliographic Details
Published in:International journal of stroke 2024-01, Vol.19 (1), p.68-75
Main Authors: Schleicher, Riana L, Vorasayan, Pongpat, McCabe, Megan E, Bevers, Matthew B, Davis, Thomas P, Griffin, John H, Hinduja, Archana, Jadhav, Ashutosh P, Lee, Jin-Moo, Sawyer, Robert N, Zlokovic, Berislav V, Sheth, Kevin N, Fedler, Janel K, Lyden, Patrick, Kimberly, W Taylor
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Cerebral edema is a secondary complication of acute ischemic stroke, but its time course and imaging markers are not fully understood. Recently, net water uptake (NWU) has been proposed as a novel marker of edema. Aims: Studying the RHAPSODY trial cohort, we sought to characterize the time course of edema and test the hypothesis that NWU provides distinct information when added to traditional markers of cerebral edema after stroke by examining its association with other markers. Methods: A total of 65 patients had measurable supratentorial ischemic lesions. Patients underwent head computed tomography (CT), brain magnetic resonance imaging (MRI) scans, or both at the baseline visit and after 2, 7, 30, and 90 days following enrollment. CT and MRI scans were used to measure four imaging markers of edema: midline shift (MLS), hemisphere volume ratio (HVR), cerebrospinal fluid (CSF) volume, and NWU using semi-quantitative threshold analysis. Trajectories of the markers were summarized, as available. Correlations of the markers of edema were computed and the markers compared by clinical outcome. Regression models were used to examine the effect of 3K3A-activated protein C (APC) treatment. Results: Two measures of mass effect, MLS and HVR, could be measured on all imaging modalities, and had values available across all time points. Accordingly, mass effect reached a maximum level by day 7, normalized by day 30, and then reversed by day 90 for both measures. In the first 2 days after stroke, the change in CSF volume was associated with MLS (ρ = –0.57, p = 0.0001) and HVR (ρ = –0.66, p 
ISSN:1747-4930
1747-4949
1747-4949
DOI:10.1177/17474930231187268